Aavantibio taps Wright as chief medical officer

Aavantibio, a gene therapy company, has named Dr. Christopher Wright as chief medical officer.

30 March 2021•3 mins read
private equity deals, PE Hub
LinkedInXEmail
LinkedInXEmail

Related articles